TU Darmstadt / ULB / TUprints

Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: No Grouping | Item Type | Date
Number of items: 5.

Macarrón Palacios, Arturo ; Grzeschik, Julius ; Deweid, Lukas ; Krah, Simon ; Zielonka, Stefan ; Rösner, Thies ; Peipp, Matthias ; Valerius, Thomas ; Kolmar, Harald (2024)
Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
In: Frontiers in Immunology, 2020, 11
doi: 10.26083/tuprints-00017467
Article, Secondary publication, Publisher's Version

Pekar, Lukas ; Klewinghaus, Daniel ; Arras, Paul ; Carrara, Stefania C. ; Harwardt, Julia ; Krah, Simon ; Yanakieva, Desislava ; Toleikis, Lars ; Smider, Vaughn V. ; Kolmar, Harald ; Zielonka, Stefan (2024)
Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity.
In: Frontiers in Immunology, 2021, 12
doi: 10.26083/tuprints-00019967
Article, Secondary publication, Publisher's Version

Krah, Simon ; Kolmar, Harald ; Becker, Stefan ; Zielonka, Stefan (2024)
Engineering IgG-Like Bispecific Antibodies — An Overview.
In: Antibodies, 2018, 7 (3)
doi: 10.26083/tuprints-00015758
Article, Secondary publication, Publisher's Version

Lipinski, Britta ; Arras, Paul ; Pekar, Lukas ; Klewinghaus, Daniel ; Boje, Ammelie Svea ; Krah, Simon ; Zimmermann, Jasmin ; Klausz, Katja ; Peipp, Matthias ; Siegmund, Vanessa ; Evers, Andreas ; Zielonka, Stefan (2023)
NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats.
In: Protein Science, 2023, 32 (3)
doi: 10.26083/tuprints-00023690
Article, Secondary publication, Publisher's Version

Klewinghaus, Daniel ; Pekar, Lukas ; Arras, Paul ; Krah, Simon ; Valldorf, Bernhard ; Kolmar, Harald ; Zielonka, Stefan (2022)
Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of ‘Almost Natural’ Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.
In: Frontiers in Immunology, 2022, 12
doi: 10.26083/tuprints-00020369
Article, Secondary publication, Publisher's Version

This list was generated on Mon May 27 10:09:31 2024 CEST.